BIOMAT Database Logo BIOMAT Database Logo

Effect of aerosol ipratropium bromide (SCH 1000) on sputum viscosity and volume in chronic bronchitis. 1977

C S May, and K N Palmer

UI MeSH Term Description Entries
D009241 Ipratropium A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic. N-Isopropylatropine,(endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane,Atrovent,Ipratropium Bromide,Ipratropium Bromide Anhydrous,Ipratropium Bromide Monohydrate,Ipratropium Bromide, (endo,anti)-Isomer,Ipratropium Bromide, (exo,syn)-Isomer,Ipratropium Bromide, endo-Isomer,Itrop,Sch-1000,Sch-1178,N Isopropylatropine,Sch 1000,Sch 1178,Sch1000,Sch1178
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000336 Aerosols Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents. Aerosol
D001286 Atropine Derivatives Analogs and derivatives of atropine. Atropines
D013183 Sputum Material coughed up from the lungs and expectorated via the mouth. It contains MUCUS, cellular debris, and microorganisms. It may also contain blood or pus. Sputum, Induced,Induced Sputum,Induced Sputums,Sputums,Sputums, Induced
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014783 Viscosity The resistance that a gaseous or liquid system offers to flow when it is subjected to shear stress. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Viscosities

Related Publications

C S May, and K N Palmer
Bronchodilator action of the anticholinergic drug, ipratropium bromide (Sch 1000), as an aerosol in chronic bronchitis and asthma.
March 1977, Chest,
C S May, and K N Palmer
Ipratropium bromide aerosol in chronic bronchitis.
October 1977, Irish medical journal,
C S May, and K N Palmer
Ipratropium bromide (Sch 1000) monohydrate aerosol: bronchodilator effect of three dose levels in asthmatics.
January 1978, Lung,
C S May, and K N Palmer
The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.
December 1978, Thorax,
C S May, and K N Palmer
Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.
February 1975, British medical journal,
C S May, and K N Palmer
[Effect of ipratropium bromide (Sch 1000) on the action of various bronchoactive agents (author's transl)].
August 1980, Nihon Kyobu Shikkan Gakkai zasshi,
C S May, and K N Palmer
Sputum viscosity and long-term ipratropium bromide nebuliser therapy.
May 1982, Lancet (London, England),
C S May, and K N Palmer
Effect of ipratropium bromide (atrovent) inhalation in chronic bronchitis.
January 1985, The Indian journal of chest diseases & allied sciences,
C S May, and K N Palmer
Reduction of sputum viscosity by a water aerosol in chronic bronchitis.
January 1960, Lancet (London, England),
C S May, and K N Palmer
[Studies on airway reversibility test by ipratropium bromide (Sch 1000) inhalation using partial and maximum expiratory flow-volume curve].
March 1984, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!